Herbal composition for breast cancer prevention
OwnerLaura Mann Kevehaziinventor
Life of this patent
Estimating the term…
Abstract
A composition for use in protecting the breast tissue and significantly lowering the high risk for breast cancer development in women includes Ganoderma lucidum, Quercetine, Embilica officinalis, Indole 3 carbinol, Camellia sinensis, Allium sativum, Iodine, and Selenium.
Claims21
A composition comprising multiple ingredients, each in effective amounts, which treats breast cancer in a subject in need thereof by inhibiting breast cancer cells, the composition comprising:
- a medicinal mushroom, the medicinal mushroom being one of Ganoderma lucidum, Phellinus linteus, Trametes vesicolor, Inonotus oblicus and Grifola frondosa, said medicinal mushroom in an amount of between 50-450 mg;
- Quercetin, said Quercetin in an amount of between 125 to 450 mg;
- Embilica officinalis, said Embilica officinalis in an amount of between 100-450 mg;
- Indole 3 Carbinol, said Indole 3 Carbinol in an amount of between 50-300 mg;
- Camellia sinensis, said Camellia sinensis in an amount equivalent to between 300 mg to 1800 mg;
- Allium sativum, said Allium sativum in an amount equivalent to between 1000-3000 mg;
- Iodine, said Iodine in an amount of between 100-400 mcg;
- and
- Selenium, said Selenium in an amount of between 20-120 mcg,
- wherein, said composition being encapsulated and suitable for oral administration.
A composition for use in a subject at risk of developing breast cancer by protecting breast cells from malignant changes and lowering the risk for breast cancer development, the composition comprising:
- Ganoderma lucidum in an amount from 125-375 mg;
- Quercetin Dihydrate 95% in an amount from 125-375 mg;
- Embilica officinalis in an amount from 100-300 mg;
- Indole 3 Carbinol in an amount from 50-150 mg;
- Camellia sinensis in an amount equivalent to 360-1080 mg;
- Allium sativum in an amount equivalent to 1000-3000 mg;
- Iodine in an amount from 100-300 mcg;
- and
- Selenium in an amount from 20-60 mcg,
- wherein, said composition being encapsulated in capsule format suitable for oral administration.
A composition for daily administration for women at risk of developing breast cancer arising from at least one of BRAC1 and BRAC2 mutations, high breast density, family history, and having had cancer in the past, to reduce the risk of breast cancer development, said composition comprising multiple ingredients, delivered as a capsule suitable for oral administration, comprising:
- Ganoderma lucidum in an amount from 125-375 mg;
- Quercetin Dihydrate 95% in an amount from 125-375 mg;
- Embilica officinalis in an amount from 100-300 mg;
- Indole 3 Carbinol in an amount from 50-150 mg;
- Camellia sinensis extract 12:1 in an amount from 30-90 mg;
- Allium sativum extract 100:1 in an amount from 10-30 mg;
- Iodine in an amount from 100-300 mcg;
- and
- Selenium in an amount from 20-60 mcg.
A composition for inhibiting breast cancer proliferation by administering a daily dose of the composition, said composition in a dosage form for oral delivery, comprising:
- Ganoderma lucidum from 125-450 mg;
- Quercetin Dihydrate 95% from 125-450 mg;
- Embilica officinalis from 100-300 mg;
- Indole 3 Carbinol from 50-300 mg;
- Camellia sinensis in an amount equivalent to 300-1080 mg;
- Allium sativum in an amount equivalent to 1000-3000 mg;
- Iodine from 100-400 mcg;
- and
- Selenium from 20-120 mcg.
Dependencies are inferred from the claim text.